Influenza vaccination among Canadians with chronic respiratory disease

Respiratory Medicine

Volumn 103, Issue 1, 2009, Pages 50-58

  Vozoris, Nicholas T ^a   Lougheed, M Diane ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

Asthma; COPD; Influenza vaccination

Indexed keywords

ANTIBIOTIC AGENT; ANTITUSSIVE AGENT; INFLUENZA VACCINE; STEROID;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CANADA; CHILD; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DRUG USE; FEMALE; HEALTH SURVEY; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INHALER; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGE FACTORS; AGED; ASTHMA; ATTITUDE; BRONCHODILATOR AGENTS; CANADA; EMIGRANTS AND IMMIGRANTS; FEMALE; HEALTH SURVEYS; HUMANS; INFLUENZA VACCINES; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; ODDS RATIO; PATIENT ACCEPTANCE OF HEALTH CARE; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK; SEX FACTORS; SMOKING;

EID: 58049108392     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2008.08.004     Document Type: Article

References (49)

1. Sugaya N., Nerome K., Ishida M., Matsumoto M., Mitamurma K., and Nirasawa M. Efficacy of inactivated vaccine in preventing antigenically drifted influenza type A and well-matched type B. The Journal of the American Medical Association 272 (1994) 1122-1126
2. Johnston S.L., Pattermore P.K., Sanderson G., Smith S., Lampe F., Josephs L., et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 310 (1995) 1225-1229
3. Bueving H.J., Thomas S., and van der Wouden J.C. Is influenza vaccination in asthma helpful?. Current Opinion in Allergy and Clinical Immunology 5 (2005) 65-70
4. Carilli A.D., Cohd R.S., and Gordon W. A virologic study of chronic bronchitis. The New England Journal of Medicine 270 (1964) 123-127
5. Gump D.W., Philips C.A., Forsyth B.R., McIntosh K., Lamborn K.R., and Stouch W.H. Role of infection in chronic bronchitis. The American Review of Respiratory Disease 113 (1976) 465-470
6. Eadie M.B., Stott E.J., and Grist N.R. Virological studies in chronic bronchitis. BMJ 2 (1966) 671-673
7. Howells C.H.L., and Tyler L.E. Prophylactic use of influenza vaccination in patients with chronic bronchitis. A pilot trial. The Lancet 2 (1961) 1428-1432
8. Wongsurakiat P., Maranetra K.N., Wasi C., Kositanont A., Dejsomritrutai W., and Charoenratanakul S. Acute respiratory illness in patients with COPD and the effectiveness off influenza vaccination. Chest 125 (2004) 2011-2020
9. National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 2006-2007 season. An Advisory Committee Statement (ACS). Canada Communicable Disease Report 32 ACS-7 (2006) 1-27
10. van Essen G.A., Palache A.M., Forleo E., and Fedson D.S. Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries. Vaccine 21 (2003) 1780-1785
11. Global strategy for asthma management and prevention, Global Initiative for Asthma (GINA) (2007). http://www.ginasthma.org
12. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease, Global Strategy for Chronic Obstructive Lung Disease (GOLD) (2006). http://www.goldcopd.org
13. Egede L.E., and Zheng D. Racial/ethnic differences in influenza vaccination coverage in high-risk adults. American Journal of Public Health 93 (2003) 2074-2078
14. Centre for Disease Control and Prevention. Influenza and pneumococcal vaccination coverage among persons aged ≥65 years and persons aged 18-64 years with diabetes or asthma - United States. Morbidity and Mortality Weekly Report 53 (2004) 1007-1012
15. Ford E.S., Mannino D.M., and Williams S.G. Asthma and influenza vaccination. Findings from the 1999-2001 National Health Interview Surveys. Chest 124 (2003) 783-789
16. Lopez-de-Andres A., Carrasco-Garrrido P., Hernandez-Barrera V., de Miguel A.G., and Jimenez-Garcia R. Coverages and factors associated with influenza vaccination among subjects with respiratory diseases in Spain. European Journal of Public Health (2007) 2-5
17. Montero E.M., Hernandez-Barrera V., Carrasco-Garrrido P., Gil de Miguel A., and Jimenez-Garcia R. Influenza vaccination among persons with chronic respiratory diseases: coverage, related factors, and time-trend, 1993-2001. Public Health 121 (2007) 113-121
18. Schoefer Y., Schaberg T., Raspe H., and Schafer T. Determinants of influenza and pneumococcal vaccination in patients with chronic lung diseases. Journal of Infection 55 (2007) 347-352
19. Cicutto L.C., and Brooks D. Self-care approaches to managing chronic obstructive pulmonary disease: a provincial survey. Respiratory Medicine 100 (2006) 1540-1546
20. Demicheli V., Rivetti D., Deeks J.J., and Jefferson T.O. Vaccines for preventing influenza in healthy adults. The Cochrane Database of Systematic Reviews 3 (2004) 10.1002/14651858.CD001269.pub2 Art. No. CD001269.pub2
21. Nichol K.L., Lind A., Margolis K.L., Murdoch M., McFadden R., Hauge M., et al. The effectiveness of vaccination against influenza in healthy working adults. The New England Journal of Medicine 333 (1995) 889-893
22. Govaert T.M., Thijs C.T., Masurel N., Sprenger M.J., Dinant G.J., and Knottnerus G.J. The efficacy of influenza vaccination in elderly individuals: a randomized double-blind placebo-controlled trials. The Journal of the American Medical Association 272 (1994) 1661-1665
23. Nichol K.L., Margolis K.L., Wuorenma J., and von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. The New England Journal of Medicine 331 (1994) 778-784
24. Nichol K.L., Wuorenma J., and Von Sternberg T. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Archives of Internal Medicine 158 (1998) 1769-1776
25. Nichol K.L., Nordin J.D., Nelson D.B., Mullooly J.P., and Hak E. Effectiveness of influenza vaccine in the community dwelling-elderly. The New England Journal of Medicine 357 (2007) 1373-1382
26. Poole P.J., Chacko E., Wood-Baker R.W.B., and Cates C.J. Influenza vaccination for patients with chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 1 (2006) 10.1002/14651858.CD002733.pub2 Art. No. CD002733
27. Wang C.S., Wang S.T., Lai C.T., Lin L.J., and Chou P. Impact of influenza vaccination on major cause-specific mortality. Vaccine 25 (2007) 1196-1203
28. Nichol K.L., Baken L., and Neslon A. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Annals of Internal Medicine 130 (1999) 397-403
29. Fell P.J., O'Donnell H.F., Watson N.P., Simmons R.L., and Haskell S.K. Longer term effects of live influenza vaccine in patients with chronic pulmonary disease. The Lancet 1 (1977) 1282-1284
30. Hak E., Hoes A.W., Grobbee D.E., Lammers J.W., van Essen G.A., van Loom A.M., et al. Conventional influenza vaccination is not associated with complications in working-age patients with asthma or chronic obstructive pulmonary disease. American Journal of Epidemiology 157 (2003) 692-700
31. Gorse G.J., O'Connor T.Z., Young S.L., Mendelman P.M., Bradley S.F., Nichol K.L., et al. Efficacy trial of live, cold-adapted and inactivated influenza virus in older adults with chronic obstructive pulmonary disease: a VA cooperative study. Vaccine 21 (2003) 2133-2144
32. Vila-Corcoles A, Ochoa O, de Diego C, Valdivieso A, Salsench E, Ansa X, et al. Effects of annual influenza vaccination on winter mortality in elderly people with chronic pulmonary disease. International Journal of Clinical Practice 2008;62:10-17.
33. Cates C.J., Jefferson T.O., Bara A.I., and Rowe B.H. Vaccines for preventing influenza in people with asthma. Cochrane Database of Systematic Reviews 4 (2003) 10.1002/14651858.CD000364.pub2 Art. No. CD000364
34. Bueving H.J., Bersen R.M., de Jongste J.C., van Suijlekom-Smit L.W., Rimmelzwaan G.M., Osterhaus A.D., et al. Influenza vaccination in children with asthma: radomized, double-blind placebo-controlled trial. Am J Respir Crit Care Med 169 (2004) 488-493
35. Abadaglu O., Mungan D., Pasaoglu G., Celik G., and Misirzigil Z. Influenza vaccination in patients with asthma: effect on the frequency of upper respiratory tract infections and exacerbations. The Journal of Asthma 41 (2004) 279-283
36. Christy C., Aligne C.A., Auinger P., Pulcino T., and Weitzman M. Effectiveness of influenza vaccination for the prevention of asthma exacerbations. Archives of Disease in Childhood 89 (2004) 734-735
37. Bergen R., Black S., Shinefield H., Lewis E., Ray P., Hansen J., et al. Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents. The Pediatric Infectious Disease Journal 23 (2004) 138-144
38. Statistics Canada, Health Statistics Division. Canadian community health survey 2003, user guide for the public use microdata file (2005), Ministry of Industry, Ottawa (Canada) Cat. No. 82M0013GPE
39. Statistics Canada, Health Statistics Division. CCHS cycle 2.1: data dictionary, public use microdata file (2005), Statistics Canada, Ottawa (Canada)
40. Beland Y. Canadian community health survey - methodological overview. Health Reports 13 3 (2002) 9-14
41. Health Canada. Publicly-funded influenza and pneumococcal immunization programs in Canada: a progress report. Canada Communicable Disease Report 26-17 (2000) 141-148
42. Kwong J.C., Sambell C., Johansen H., Stukel T.A., and Manuel D.G. The effect of universal influenza immunization on vaccination rates in Ontario. Health Reports 17 2 (2006) 31-40
43. Jimenez-Garcia R., Arinez-Fernandez M.C., Hernandez-Barrera V., Garcia-Carballo M.M., de Miguel A.G., and Carrasco-Garrido P. Compliance with influenza and pneumococcal vaccination among patients with chronic obstructive pulmonary disease consulting their medical professionals in Catalonia, Spain. Journal of Infection 54 (2007) 65-74
44. Honkanen P.O., Keistinen T., and Kivels S.L. The impact of vaccination strategy and methods of information on influenza and pneumococcal vaccination coverage in the elderly population. Vaccine 15 (1997) 317-320
45. Stallberg B., Lisspers K., Hasselgren M., Johansson G., and Svardsudd K. Factors related to the level of severity of asthma in primary care. Respiratory Medicine 101 (2007) 2076-2083
46. McCoy K., Shade D.M., Irvin C.G., Mastronarde J.G., Hanania N.A., Castro M., et al. Predicting episodes of poor asthma control in treated patients with asthma. Journal of Allergy and Clinical Immunology 118 (2006) 1226-1233
47. Tsai C.L., Clark S., Cydulka R.K., Rowe B.H., and Camargo Jr. C.A. Factors associated with hospital admission among emergency department patients with chronic obstructive pulmonary disease exacerbation. Academic Emergency Medicine 14 (2007) 6-14
48. Furey A., Robinson E., and Young Y. Improving influenza immunisation coverage in 2000-2001: a baseline survey, review of the evidence and sharing of best practice. Communicable Disease and Public Health 4 (2001) 183-187
49. Conseil d'evaluation des technologies en sante du Quebec. Cout-efficacite et cout-utilite d'un programme d'immunisation le pneumocoque au Quebec (1998), CETS, Montreal, Quebec